EarningsQ2 2024 Earnings Report

Vertex Pharmaceuticals (1VRTX) Q2 2024 Earnings Report

4 Followers

IT:1VRTX Q2 2024 EPS Results

Actual EPS-€11.42

Consensus EPS-€10.34

Beat/MissMissed by -€1.07

One Year Ago EPS€3.46

Actual Revenue€2.34B

Expected Revenue€2.37B

Beat/MissMissed by -€25.77M

YoY Revenue Growth+6.02%

QuarterQ2 2024

Date08/01/2024

TimeAfter Close

Conference CallThursday, August 1, 2024

IT:1VRTX Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

IT:1VRTX Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	4.24 / -	4.271	―
Aug 03, 2026	2026 (Q2)	4.22 / 4.21	4.022	4.65% (+0.19)
May 04, 2026	2026 (Q1)	3.78 / 3.98	3.613	10.10% (+0.36)
Feb 12, 2026	2025 (Q4)	4.55 / 4.48	3.541	26.38% (+0.93)
Nov 03, 2025	2025 (Q3)	4.07 / 4.27	3.897	9.59% (+0.37)
Aug 06, 2025	2025 (Q2)	3.82 / 4.02	-11.416	135.23% (+15.44)
May 05, 2025	2025 (Q1)	3.84 / 3.61	4.235	-14.71% (-0.62)
Feb 10, 2025	2024 (Q4)	3.57 / 3.54	3.737	-5.24% (-0.20)
Nov 04, 2024	2024 (Q3)	3.63 / 3.90	3.63	7.35% (+0.27)
Aug 01, 2024	2024 (Q2)	-10.34 / -11.42	3.461	-429.82% (-14.88)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed